Cargando…
Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice
BACKGROUND: Liver fibrosis is characterized by excessive synthesis of extracellular matrix proteins, which prevails over their enzymatic degradation, primarily by matrix metalloproteinases (MMPs). The effect of pharmacological MMP inhibition on fibrogenesis, however, is largely unexplored. Inflammat...
Autores principales: | de Meijer, Vincent E., Sverdlov, Deanna Y., Popov, Yury, Le, Hau D., Meisel, Jonathan A., Nosé, Vânia, Schuppan, Detlef, Puder, Mark |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892485/ https://www.ncbi.nlm.nih.gov/pubmed/20593020 http://dx.doi.org/10.1371/journal.pone.0011256 |
Ejemplares similares
-
Tumor Necrosis Factor α-Converting Enzyme Inhibition Reverses Hepatic Steatosis and Improves Insulin Sensitivity Markers and Surgical Outcome in Mice
por: de Meijer, Vincent E., et al.
Publicado: (2011) -
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
por: Kaps, Leonard, et al.
Publicado: (2020) -
Matrix Metalloproteinase Gene Delivery for Liver Fibrosis
por: Iimuro, Yuji, et al.
Publicado: (2007) -
Matrix metalloproteinases in liver injury, repair and fibrosis
por: Duarte, Sergio, et al.
Publicado: (2015) -
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
por: Ikenaga, Naoki, et al.
Publicado: (2017)